Scapa Group, which supplies adhesive bonding for electronics and medical equipment, yesterday splashed out up to $45m (£29m) to buy US rival Webtec Converting.
The Manchester-based firm said the acquisition would boost its medical expertise, particularly in such fast-growing areas as advanced woundcare and silicone-based dressings. Scapa shares rose 8.5 per cent to 51p on the news of the deal.
Scapa will pay $30m upfront to Webtec, whose chief executive Randy Holmes is the principal shareholder. A further payment of up to $15m is dependent on hitting profit targets.
- More about:
- Corporate Finance
- Financial Regulation
- Mergers And Acquisitions
- Stock And Equity Market And Stock Exchange